(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202506 | 202406 | % Var | 202506 | 202406 | % Var | 202503 | 202403 | % Var | |
| Sales | 0.93 | 0.79 | 17.72 | 0.93 | 0.79 | 17.72 | 6.11 | 5.55 | 10.09 |
| Other Income | 5.34 | 4.57 | 16.85 | 5.34 | 4.57 | 16.85 | 20.09 | 19.92 | 0.85 |
| PBIDT | 2.57 | 1.83 | 40.44 | 2.57 | 1.83 | 40.44 | 10.58 | 9.10 | 16.26 |
| Interest | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| PBDT | 2.56 | 1.83 | 39.89 | 2.56 | 1.83 | 39.89 | 10.57 | 9.10 | 16.15 |
| Depreciation | 0.25 | 0.24 | 4.17 | 0.25 | 0.24 | 4.17 | 0.98 | 0.98 | 0.00 |
| PBT | 2.31 | 1.59 | 45.28 | 2.31 | 1.59 | 45.28 | 9.59 | 8.12 | 18.10 |
| TAX | 0.60 | 0.69 | -13.04 | 0.60 | 0.69 | -13.04 | 6.42 | 1.62 | 296.30 |
| Deferred Tax | 0.00 | 0.39 | -100.00 | 0.00 | 0.39 | -100.00 | 2.02 | 1.49 | 35.57 |
| PAT | 1.71 | 0.90 | 90.00 | 1.71 | 0.90 | 90.00 | 3.17 | 6.50 | -51.23 |
| Equity | 49.96 | 49.96 | 0.00 | 49.96 | 49.96 | 0.00 | 49.96 | 49.96 | 0.00 |
| PBIDTM(%) | 276.34 | 231.65 | 19.30 | 276.34 | 231.65 | 19.30 | 173.16 | 163.96 | 5.61 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1688.00 |
| Dr. Reddys Lab | 1217.50 |
| Cipla | 1225.50 |
| Zydus Lifesciences | 933.65 |
| Lupin | 2337.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: